SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-21-000138
Filing Date
2021-02-12
Accepted
2021-02-12 15:56:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 lumos13ga1-021221.htm SC 13G/A 230565
  Complete submission text file 0001013594-21-000138.txt   232175
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Subject) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86491 | Film No.: 21626889
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019 212-356-6200
Lion Point Capital, LP (Filed by) CIK: 0001643354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A